Titan Medical to Present and Exhibit at the Society of Robotic Surgery 2018 Annual Meeting
June 13 2018 - 7:15AM
Titan Medical Inc. (“Titan” or the “Company”)
(TSX:TMD) (OTCQB:TITXF), a medical device company focused on the
design, development and commercialization of a robotic surgical
system for application in minimally invasive surgery (“MIS”),
announces that David McNally, President and CEO of Titan Medical,
will present in the plenary session on Monday, June 18 at the
Society of Robotic Surgery 2018 Annual Meeting in Stockholm. This
industry-focused plenary session will feature executives from
companies recognized for current and promising technology platforms
in robotic surgery.
Two abstracts highlighting multi-disciplinary
preclinical work from two of Titan’s Centers of Excellence, Florida
Hospital Nicholson Center and IHU Strasbourg, will be presented at
the meeting in the form of Poster Presentations. These abstracts
will also be included in the Journal of Robotic Surgery,
a peer-reviewed medical
journal covering robotic surgery and an official journal
of SRS. The SPORT Surgical System will also be highlighted in
several presentations in General Surgery, Gynecology and Colorectal
tracks throughout the meeting. Titan Medical will showcase its
technology and multi-specialty preclinical feasibility videos at
its booth in the Exhibit Hall.
David McNally, President and CEO of Titan
Medical, said, “We are delighted with our comprehensive
participation in the Society of Robotic Surgery 2018 Annual
Meeting, where we will be among clinical and industry experts in
the field of robotic surgery. The acceptance of two abstracts
highlighting our preclinical feasibility work and several
presentations referencing the SPORT Surgical System as a promising
single-port robotic technology platform further demonstrates
enthusiasm for single-port robotic surgery in a variety of surgical
disciplines. We look forward to sharing our vision and commitment
to advancing robotic surgery during the industry plenary session on
the first day of the meeting.”
The Society of Robotic Surgery 2018 Annual
Meeting is designed to be the most comprehensive robotic
surgery symposium, featuring internationally renowned faculty who
are dedicated experts in their fields of study.
About Titan Medical Inc.
Titan Medical Inc. is focused on research and
development through to the planned commercialization of
computer-assisted robotic surgical technologies for application in
minimally invasive surgery. The Company is developing the SPORT
Surgical System, a single-port robotic surgical system. The SPORT
Surgical System is comprised of a surgeon-controlled patient cart
that includes a 3D high-definition vision system and
multi-articulating instruments for performing MIS procedures, and a
surgeon workstation that provides an advanced ergonomic interface
to the patient cart and a 3D endoscopic view inside the patient’s
body. Titan intends to initially pursue focused surgical
indications for the SPORT Surgical System, which may include one or
more of gynecologic, urologic, colorectal or general abdominal
procedures.
For more information, please visit the Company’s
website at www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking
statements” which reflect the current expectations of management of
the Company’s future growth, results of operations, performance and
business prospects and opportunities. Wherever possible, words such
as “may”, “would”, “could”, “will”, “anticipate”, “believe”,
“plan”, “expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 31, 2018 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance, or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure current or
prospective investors that actual results, performance or
achievements will be consistent with these forward-looking
statements.
Contacts:
LHA Investor Relations Kim Sutton Golodetz(212)
838-3777kgolodetz@lhai.com orBruce Voss(310)
691-7100bvoss@lhai.com
Titan Medical (TSX:TMD)
Historical Stock Chart
From Apr 2024 to May 2024
Titan Medical (TSX:TMD)
Historical Stock Chart
From May 2023 to May 2024